Literature DB >> 33396266

The Role of CDK5 in Tumours and Tumour Microenvironments.

Phuong Anh Do1, Chang Hoon Lee1.   

Abstract

Cyclin-dependent kinase 5 (CDK5), which belongs to the protein kinase family, regulates neuronal function but is also associated with cancer development and has been proposed as a target for cancer treatment. Indeed, CDK5 has roles in cell proliferation, apoptosis, angiogenesis, inflammation, and immune response. Aberrant CDK5 activation triggers tumour progression in numerous types of cancer. In this review, we summarise the role of CDK5 in cancer and neurons and CDK5 inhibitors. We expect that our review helps researchers to develop CDK5 inhibitors as treatments for refractory cancer.

Entities:  

Keywords:  CDK5; cancer; microtubule; neuron; tumour microenvironments

Year:  2020        PMID: 33396266     DOI: 10.3390/cancers13010101

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  8 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

2.  CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients.

Authors:  Dan Wang; Yanhong Zhou; Li Hua; Jiaxiang Li; Ni Zhu; Yifei Liu
Journal:  Int J Gen Med       Date:  2022-02-27

3.  Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice.

Authors:  Benjamin Thilo Krüger; Lena Steppe; Sabine Vettorazzi; Melanie Haffner-Luntzer; Sooyeon Lee; Ann-Kristin Dorn; Anita Ignatius; Jan Tuckermann; Mubashir Ahmad
Journal:  Biomedicines       Date:  2022-02-08

4.  CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration.

Authors:  Xabier Morales; Rafael Peláez; Saray Garasa; Carlos Ortiz de Solórzano; Ana Rouzaut
Journal:  Biomolecules       Date:  2021-10-18

5.  The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer.

Authors:  Rongrong Xie; Mengping Yuan; Yiyan Jiang
Journal:  Front Cell Dev Biol       Date:  2022-03-02

6.  Cyclin-dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c-5p/cell division cycle 25B pathway and is associated with a poor prognosis.

Authors:  Yixuan Li; Fan Yao; Zan Jiao; Xuan Su; Tong Wu; Jin Peng; Zhongyuan Yang; Weichao Chen; Ankui Yang
Journal:  Cancer       Date:  2022-02-10       Impact factor: 6.921

7.  Cyclin-dependent kinase 5 contributes to apoptosis of vascular endothelial cells during aortic dissection.

Authors:  Jingyong Huang; Anthony Lemaire; Chongqing Huang
Journal:  Ann Transl Med       Date:  2022-08

Review 8.  Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.

Authors:  Jingjing Qu; Quanhui Mei; Lijun Chen; Jianying Zhou
Journal:  Cancer Immunol Immunother       Date:  2020-10-06       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.